Article info
PDFTherapeutics
Review: interferon and nucleoside/tide analogues reduce risk of hepato-cellular cancer in chronic hepatitis B
Citation
Review: interferon and nucleoside/tide analogues reduce risk of hepato-cellular cancer in chronic hepatitis B
Publication history
- First published May 29, 2009.
Online issue publication
May 29, 2009
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 by the BMJ Publishing Group Ltd for Evidence-Based Medicine and by the ACP for portions reproduced from ACP Journal Club